Lynda Sarah Cranston - Net Worth and Insider Trading
Lynda Sarah Cranston Net Worth
The estimated net worth of Lynda Sarah Cranston is at least $0 dollars as of 2024-11-13. Lynda Sarah Cranston is the Director of Kintara Therapeutics Inc and owns about 0 shares of Kintara Therapeutics Inc (KTRA) stock worth over $0. Details can be seen in Lynda Sarah Cranston's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Lynda Sarah Cranston has not made any transactions after 2017-06-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Lynda Sarah Cranston
Lynda Sarah Cranston Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Lynda Sarah Cranston owns 1 companies in total, including Kintara Therapeutics Inc (KTRA) .
Click here to see the complete history of Lynda Sarah Cranston’s form 4 insider trades.
Insider Ownership Summary of Lynda Sarah Cranston
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KTRA | Kintara Therapeutics Inc | 2017-12-31 | director |
Lynda Sarah Cranston Latest Holdings Summary
Lynda Sarah Cranston currently owns a total of 1 stock. Lynda Sarah Cranston owns 0 shares of Kintara Therapeutics Inc (KTRA) as of June 26, 2017, with a value of $0.
Latest Holdings of Lynda Sarah Cranston
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KTRA | Kintara Therapeutics Inc | 2017-06-26 | 0 | 7.54 | 0 |
Holding Weightings of Lynda Sarah Cranston
Lynda Sarah Cranston Form 4 Trading Tracker
According to the SEC Form 4 filings, Lynda Sarah Cranston has made a total of 0 transactions in Kintara Therapeutics Inc (KTRA) over the past 5 years. The most-recent trade in Kintara Therapeutics Inc is the acquisition of 0 shares on June 26, 2017, which cost Lynda Sarah Cranston around $7,499.
Insider Trading History of Lynda Sarah Cranston
- 1
Lynda Sarah Cranston Trading Performance
GuruFocus tracks the stock performance after each of Lynda Sarah Cranston's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Lynda Sarah Cranston is -56.88%. GuruFocus also compares Lynda Sarah Cranston's trading performance to market benchmark return within the same time period. The performance of stocks bought by Lynda Sarah Cranston within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Lynda Sarah Cranston's insider trading performs compared to the benchmark.
Performance of Lynda Sarah Cranston
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -3.67 | | | | | |
| Relative Return to S&P 500(%) | -5.26 | | | | | |
Lynda Sarah Cranston Ownership Network
Ownership Network List of Lynda Sarah Cranston
Ownership Network Relation of Lynda Sarah Cranston
Lynda Sarah Cranston Owned Company Details
What does Kintara Therapeutics Inc do?
Who are the key executives at Kintara Therapeutics Inc?
Lynda Sarah Cranston is the director of Kintara Therapeutics Inc. Other key executives at Kintara Therapeutics Inc include director & President and CEO Robert Hoffman , Chief Financial Officer Anthony Scott Praill , and director & Head of Strategic Partnerships Saiid Zarrabian .
Kintara Therapeutics Inc (KTRA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Kintara Therapeutics Inc (KTRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kintara Therapeutics Inc (KTRA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Kintara Therapeutics Inc (KTRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kintara Therapeutics Inc Insider Transactions
Lynda Sarah Cranston Mailing Address
Above is the net worth, insider trading, and ownership report for Lynda Sarah Cranston. You might contact Lynda Sarah Cranston via mailing address: 4316 Locarno Crescent, Vancouver A1 V6r 1g3.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
